- 1. Liedberg F. et al. Diagnostic delay and prognosis in invasive bladder cancer. Scandinavian Journal of Urology and Nephrology Volum 37, 2003 – Issue 5.
- 2. M. Honore et al. Benefits of a single use IsirisTM stent removal device in the outpatient setting. USANZ Congres, 2018.
- 3. A. Pietropaolo et al. Comparison of ureteric stent removal procedures using reusable and single-use flexible cystoscopes following ureteroscopy and lasertripsy: A micro costing analysis. CEJU July 24, 2020
How could Isiris α improve waiting time for cancer follow-up?
Isiris α allows to reduce the overbooking of the operating rooms/endoscopy rooms and help hospitals to reduce the diagnostic and cancer follow-up delays.
Today, the endoscopy room is largely used for procedures as diagnosis checks, tumour ablation, botox injection, biopsy, stent placement and stent removal.
Best of testimonials
What was the previous pathway for stent removal?
“Before the introduction of Isiris α, our stents were all taken out in the endoscopy suite. The endoscopy suite is where we undertake all our cystoscopies for the urology department and there were considerable pressures in the endoscopy suite, particularly for follow-up flexible cystoscopies for patients with bladder cancer and also for diagnostic pathways such as the two week wait haematuria pathway. By removing the stent removals from the endoscopy suite and by the stent removals being undertaken in the lithotripsy suite by our specialist nurse, we freed up capacity allowing our hospital to meet the cancer targets for the two week wait haematuria patients.”